Premier PE Ratio 2012-2024 | PINC
Current and historical p/e ratio for Premier (PINC) from 2012 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Premier PE ratio as of February 28, 2025 is 10.82.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Premier PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-02-28 | 18.18 | 0.00 | |
| 2024-12-31 | 21.20 | $-0.10 | 0.00 |
| 2024-09-30 | 19.82 | $1.36 | 14.57 |
| 2024-06-30 | 18.31 | $1.03 | 17.78 |
| 2024-03-31 | 21.44 | $0.64 | 33.50 |
| 2023-12-31 | 21.47 | $1.39 | 15.45 |
| 2023-09-30 | 20.44 | $1.48 | 13.81 |
| 2023-06-30 | 26.04 | $1.47 | 17.72 |
| 2023-03-31 | 30.22 | $1.54 | 19.62 |
| 2022-12-31 | 32.45 | $1.47 | 22.07 |
| 2022-09-30 | 31.29 | $1.55 | 20.18 |
| 2022-06-30 | 32.69 | $2.16 | 15.14 |
| 2022-03-31 | 32.44 | $2.31 | 14.04 |
| 2021-12-31 | 37.32 | $2.38 | 15.68 |
| 2021-09-30 | 34.94 | $2.12 | 16.48 |
| 2021-06-30 | 31.20 | $2.57 | 12.14 |
| 2021-03-31 | 30.18 | $1.86 | 16.23 |
| 2020-12-31 | 31.12 | $2.01 | 15.48 |
| 2020-09-30 | 28.95 | $-5.22 | 0.00 |
| 2020-06-30 | 30.06 | $-6.15 | 0.00 |
| 2020-03-31 | 28.69 | $-10.49 | 0.00 |
| 2019-12-31 | 33.21 | $-10.55 | 0.00 |
| 2019-09-30 | 25.36 | $-2.99 | 0.00 |
| 2019-06-30 | 34.29 | $-16.28 | 0.00 |
| 2019-03-31 | 30.24 | $-17.80 | 0.00 |
| 2018-12-31 | 32.75 | $-20.21 | 0.00 |
| 2018-09-30 | 40.14 | $-18.88 | 0.00 |
| 2018-06-30 | 31.90 | $-3.68 | 0.00 |
| 2018-03-31 | 27.45 | $-3.61 | 0.00 |
| 2017-12-31 | 25.59 | $-3.26 | 0.00 |
| 2017-09-30 | 28.56 | $-4.19 | 0.00 |
| 2017-06-30 | 31.56 | $-6.33 | 0.00 |
| 2017-03-31 | 27.91 | $0.07 | 398.69 |
| 2016-12-31 | 26.62 | $2.08 | 12.80 |
| 2016-09-30 | 28.36 | $-0.32 | 0.00 |
| 2016-06-30 | 28.67 | $-0.34 | 0.00 |
| 2016-03-31 | 29.25 | $-2.88 | 0.00 |
| 2015-12-31 | 30.92 | $-13.35 | 0.00 |
| 2015-09-30 | 30.14 | $-12.97 | 0.00 |
| 2015-06-30 | 33.72 | $-15.79 | 0.00 |
| 2015-03-31 | 32.95 | $1.54 | 21.40 |
| 2014-12-31 | 29.40 | $27.88 | 1.05 |
| 2014-09-30 | 28.81 | $28.85 | 1.00 |
| 2014-06-30 | 25.43 | $31.38 | 0.81 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.690B | $1.346B |
| Premier, Inc. operates as a healthcare alliance. The company brings together hospitals, health systems, physicians and other healthcare providers primarily in the United States. It also maintains clinical, financial and outcomes databases. Premier, Inc. is headquartered in Charlotte, North Carolina. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $150.904B | 28.19 |
| Elevance Health (ELV) | United States | $87.590B | 11.69 |
| CVS Health (CVS) | United States | $79.455B | 11.63 |
| Cencora (COR) | United States | $47.362B | 17.19 |
| DiDi Global (DIDIY) | China | $23.670B | 0.00 |
| Natera (NTRA) | United States | $20.908B | 0.00 |
| ICON (ICLR) | Ireland | $16.429B | 14.61 |
| Revvity (RVTY) | United States | $13.985B | 23.45 |
| BioMerieux (BMXMF) | France | $13.758B | 0.00 |
| Viatris (VTRS) | United States | $13.595B | 4.19 |
| Doximity (DOCS) | United States | $13.537B | 70.40 |
| Solventum (SOLV) | United States | $13.178B | 0.00 |
| Avantor (AVTR) | United States | $11.895B | 17.47 |
| CochLear (CHEOY) | Australia | $11.072B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.491B | 27.26 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.952B | 0.00 |
| HealthEquity (HQY) | United States | $9.484B | 47.58 |
| Charles River Laboratories (CRL) | United States | $8.719B | 16.52 |
| Sonic Healthcare (SKHHY) | Australia | $8.501B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
| Bausch + Lomb (BLCO) | Canada | $5.573B | 25.50 |
| Organon (OGN) | United States | $3.884B | 3.96 |
| Sotera Health (SHC) | United States | $3.814B | 20.40 |
| BrightSpring Health Services (BTSG) | United States | $3.382B | 71.93 |
| Surgery Partners (SGRY) | United States | $3.198B | 36.46 |
| Concentras Parent (CON) | United States | $2.951B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.613B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.610B | 316.67 |
| Ardent Health Partners (ARDT) | United States | $2.014B | 0.00 |
| PACS (PACS) | United States | $1.980B | 0.00 |
| Progyny (PGNY) | United States | $1.961B | 39.71 |
| Teladoc Health (TDOC) | United States | $1.961B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.845B | 48.40 |
| Agilon Health (AGL) | United States | $1.500B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.346B | 11.28 |
| CareDx (CDNA) | United States | $1.146B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.026B | 8.12 |
| Establishment Labs Holdings (ESTA) | $0.986B | 0.00 | |
| Embecta (EMBC) | United States | $0.798B | 5.47 |
| Auna S.A (AUNA) | Luxembourg | $0.598B | 0.00 |
| SBC Medicals (SBC) | United States | $0.484B | 0.00 |
| MultiPlan (MPLN) | United States | $0.472B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.472B | 0.00 |
| DocGo (DCGO) | United States | $0.453B | 17.08 |
| InnovAge Holding (INNV) | United States | $0.449B | 0.00 |
| Enhabit (EHAB) | United States | $0.406B | 35.09 |
| QDM (QDMI) | Hong Kong, SAR China | $0.335B | 8.78 |
| Nutex Health (NUTX) | United States | $0.314B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.253B | 0.00 |
| LifeMD (LFMD) | United States | $0.248B | 0.00 |
| Beauty Health (SKIN) | United States | $0.194B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.193B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.140B | 0.00 |
| Biodesix (BDSX) | United States | $0.122B | 0.00 |
| So-Young (SY) | China | $0.116B | 19.63 |
| Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.078B | 0.00 |
| ModivCare (MODV) | United States | $0.071B | 3.85 |
| Oncology Institute (TOI) | United States | $0.064B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| OncoCyte (OCX) | United States | $0.046B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.014B | 0.00 |
| KindlyMD (KDLY) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |